{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:19:13Z","timestamp":1788257953163,"version":"build-2803163510"},"reference-count":14,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>Antibody therapeutics now span across oncology, infectious disease, and autoimmunity, and the molecules entering development are increasingly being engineered rather than merely selected [...]<\/jats:p>","DOI":"10.3390\/antib15050078","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:36Z","timestamp":1788256116000},"page":"78","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Festschrift Celebrating Dr. Dimiter Stanchev Dimitrov: Antibodies, Innovation, and Impact on Infectious Disease and Cancer Research"],"prefix":"10.3390","volume":"15","author":[{"given":"Ponraj","family":"Prabakaran","sequence":"first","affiliation":[{"name":"PMJ Technology Solutions LLC, Frederick, MD 21704, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9597-2843","authenticated-orcid":false,"given":"Tianlei","family":"Ying","sequence":"additional","affiliation":[{"name":"Antibody Engineering and Drug Discovery Group, MOE\/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, 131 Dong An Road, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41577-025-01207-9","article-title":"Fifty years of monoclonals: The past, present and future of antibody therapeutics","volume":"25","author":"Chan","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12929-025-01190-2","article-title":"Technological advancements in antibody-based therapeutics for treatment of diseases","volume":"32","author":"Lu","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s13238-017-0457-8","article-title":"Current progress in innovative engineered antibodies","volume":"9","author":"Strohl","year":"2018","journal-title":"Protein Cell"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Akinsulie, O.C., Ulusan, S., Idris, I., Shahzad, S., Okon, J., Ukauwa, C., Oladoye, M., Aliyu, V., Ugwu, C.E., and Ayandokun, T. (2026). Advances in Antibody Engineering for Therapeutic Development: Molecular Strategies and Clinical Applications. Immuno, 6.","DOI":"10.3390\/immuno6020023"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(00)80460-2","article-title":"How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity","volume":"91","author":"Dimitrov","year":"1997","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrmicro817","article-title":"Virus entry: Molecular mechanisms and biomedical applications","volume":"2","author":"Dimitrov","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17121","DOI":"10.1073\/pnas.0805297105","article-title":"Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/mabs.1.1.7480","article-title":"Engineered CH2 domains (nanoantibodies)","volume":"1","author":"Dimitrov","year":"2009","journal-title":"mAbs"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/mabs.2.3.11779","article-title":"Therapeutic antibodies, vaccines and antibodyomes","volume":"2","author":"Dimitrov","year":"2010","journal-title":"mAbs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1172\/JCI83092","article-title":"Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition","volume":"126","author":"Cherkassky","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_11","first-page":"E6623","article-title":"Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.chembiol.2019.09.006","article-title":"From catalytic antibodies to antibody-drug conjugates","volume":"26","author":"Dimitrov","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"29832","DOI":"10.1073\/pnas.2010197117","article-title":"Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/15\/5\/78\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:03:15Z","timestamp":1788256995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/15\/5\/78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["antib15050078"],"URL":"https:\/\/doi.org\/10.3390\/antib15050078","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}